Page 2 Cipla: Latest News and Updates, Top Stories, Videos, Photos About Cipla

Stock Market Live Updates:Sensex, Nifty Close In Red; Indian Rupee Falls

The Indian benchmark indices Sensex and Nifty 50 closed in the red on Monday. At market close Sensex was down 0.21% at 65,655.15, while Nifty slipped 0.19% at 19,694 points. The Indian rupee closed lower today at 83.34 against the US ...

Motilal Oswal, PL Bullish On Large Cap Pharma Stock, Recommend Buy For Gain

Two leading brokerages have recommended buy call to large cap pharmaceuticals sector stock Cipla Ltd after the company declared its quarterly results. The pharmaceuticals company on October 27 announced a rise of 43.3% in its profit to Rs 1130.91 crore as ...

Cipla Q2: Profit Soars 43% To Rs 1130.91 Crore, Shares Rally Over 2%

Leading pharmaceuticals company Cipla Ltd today declared a surge of 43.3% in its profit to Rs 1130.91 crore as compared to Rs 788.90 crore in the corresponding quarter of FY 2023, beating estimates. The company declared its revenue from operations as ...

Geopolitical Tensions Take Toll Market; Sensex, Nifty Slip For 5th Consecutive Day

The Indian stock market witnessed a challenging week, as geopolitical tensions rattled investor confidence, leading to the Sensex and Nifty 50 sliding for five consecutive sessions. This is the first time such a streak has occurred since March, marking a grim ...

Cipla Stock Races Toward 52-Week High On Buzz That Bain, Dr Reddy Plan Joint Bid For Promoter Stake

Strong buying has been recorded in drugmaker, Cipla on Wednesday as the stock races toward its 52-week high of Rs 1,277.55 apiece on BSE. Cipla shares have rallied more than 2% on the exchange. The reason behind the stellar upside is ...

Cipla To Acquire South Africa-Based Actor Pharma To Expand Its OTC Biz

Drug major Cipla on Monday said its unit has inked a pact to acquire South Africa-based Actor Pharma. Cipla South Africa, a wholly-owned subsidiary of the Mumbai-based drug major, has inked a binding term sheet with Actor Holdings (Pty) Ltd to ...

Blackstone Intends To Acquire Stake In Cipla: Reports

U.S.-based private equity fund Blackstone (BX.N) will submit a bid next week to acquire a 33.47% stake in Indian drugmaker Cipla (CIPL.NS), the Economic Times reported on Friday, citing people in the know., reports Reuters According to Reuters, The stake sale will formally start the exit ...

Large Cap Pharma Company Announces 45% Jump In Profit, Rs 8.5 Dividend

Large cap pharmaceutical sector company, Cipla Ltd on Friday reported its consolidated net profit to Rs 526 crore for the quarter ended March 31, up 45% as against Rs 362 crore announced in the year ago period. Meanwhile, revenue from operations ...

6 Good Quality Mid Cap, Large Cap Stocks Trading Near Their 52-Week Low Prices

6 good quality large cap stocks are currently trading near their 52-week low prices. These stocks are Cipla, Infosys, Kotak Mahindra Bank, Wipro, Asian Paints, and Tata Power Company Ltd. Check details about these stocks below: 1. Infosys: Last trading ...

Motilal Oswal Retains Neutral Rating To Large Cap Pharma Stock, TP Rs 990

Motilal Oswal has assigned neutral call to large cap pharmaceuticals sector stock, Cipla Ltd with a target price of Rs 990 apiece, implying an upside of 10%. Last trading price of Cipla is Rs 899.85 apiece. According to the analyst, "We ...

Sharekhan Has Hold Call On 2 Large Cap Pharmaceuticals Sector Stocks

Sharekhan by BNP Paribas has assigned hold rating to 2 large cap stocks operating in Pharmaceuticals Sector. These 2 stocks are Cipla Ltd and Aurobindo Pharma Ltd. If you hold shares of these 2 large caps, you can potentially get 14% return. Check details below: ...

Kotak Securities Picked These 7 Quality Stocks To Buy & Add In January For Return Up To 58%

Kotak Securities, a renowned brokerage firm, has picked 7 stocks as its Top Picks for January 2023 with "Buy" and "Add" ratings. With an attractive valuation, the brokerage claims robust gains in the stocks in 2023. The listed 7 stocks are ...

Cipla News